Full Text View
Tabular View
No Study Results Posted
Related Studies
Study of INS37217 Inhalation Solution in Mild to Moderate Cystic Fibrosis Lung Disease
This study has been completed.
Study NCT00056147   Information provided by Merck

First Received on March 6, 2003.   Last Updated on September 13, 2005   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Cystic Fibrosis
Additional conditions recognized in this trial
Fibrosis
Lung Diseases
Pulmonary Fibrosis
More general conditions related to this trial
Digestive System Diseases
Genetic Diseases, Inborn
Infant, Newborn, Diseases
Pancreatic Diseases
Pathologic Processes
Respiratory Tract Diseases
Interventions listed in this trial
denufosol tetrasodium (INS37217)
Sponsors listed in this trial
Merck
Cystic Fibrosis Foundation


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services